The Net Margin of Chengdu Easton Biopharmaceuticals Co Ltd (688513.SS) is 20.28%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2023-12-31 | 20.28% |
2022-12-31 | 21.06% |
2021-12-31 | 22.72% |
2020-12-31 | 19.33% |
2019-12-31 | 11.47% |
2018-12-31 | 17.56% |
2017-12-31 | 13.52% |